Dr. Targan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8700 Beverly Blvd
Los Angeles, CA 90048Phone+1 310-423-7723Fax+1 310-423-0224
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Gastroenterology, 1976 - 1978
- Los Angeles County-Harbor-UCLA Medical CenterFellowship, Infectious Disease, 1975 - 1976
- Los Angeles County-Harbor-UCLA Medical CenterResidency, Internal Medicine, 1971 - 1975
- Johns Hopkins University School of MedicineClass of 1971
Certifications & Licensure
- CA State Medical License 1972 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- Top Doctors:LA Area Castle Connolly, 2013
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Join now to see all
Publications & Presentations
PubMed
- 171 citationsCCR9–Positive lymphocytes and thymus-expressed chemokine distinguish small bowel from colonic Crohn's disease ☆ ☆☆Konstantinos A. Papadakis, John Prehn, Sofia T. Moreno, Lorna Cheng, Elias A. Kouroumalis
Gastroenterology. 2001-08-01 - 2257 citationsA Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease GeneRichard H. Duerr, Kent D. Taylor, Steven R. Brant, John D. Rioux, Mark S. Silverberg
Science. 2006-12-01 - 2725 citationsHost-microbe interactions have shaped the genetic architecture of inflammatory bowel diseaseLuke Jostins, Stephan Ripke, Rinse K. Weersma, Richard H. Duerr, Dermot P.B. McGovern
Nature. 2012-11-01
Journal Articles
- Insights into the Genetic Epidemiology of Crohn's and Rare Diseases in the Ashkenazi Jewish PopulationStephan Targan, Nir Barzilai, Steven R Brant, Manuel A Rivas, PLoS One
Press Mentions
- Clinical Study Shows Efficacy of Monoclonal Antibody Treatment for Ulcerative ColitisSeptember 26th, 2024
- NEJM: Results from Targeted Therapy for Ulcerative Colitis StudySeptember 25th, 2024
- Cedars-Sinai Expert in Genetics of Inflammatory Bowel Disease Awarded 2024 Sherman Prize for Pioneering AchievementsSeptember 18th, 2024
- Join now to see all
Grant Support
- IBD: Mucosa Specific Regulation Of Ifn-Gamma ProductionNational Institute Of Diabetes And Digestive And Kidney Diseases2006–2012
- IBD: Genetic And Immunopathologic MechanismsNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
- The Cedars-Sinai Immunobiology Training ProgramNational Institute Of Allergy And Infectious Diseases2010–2011
- Role Of TL1A In Severity Of Crohn'S Disease InflammationNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2011
- Inflammatory Bowel Disease Center: Clinical Data Repository - Tissue ProcurementNational Center For Research Resources2007–2010
- Immunopathology &Aggressive Crohn'S Disease ImmunophenotypeNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2009
- Flagellin Reactivity As A Marker For A Subtype Of Crohn'S DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2009
- Core--Tissue Procurement &Data Analysis &Serum AnalysisNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2009
- Core ANational Institute Of Diabetes And Digestive And Kidney Diseases2007–2009
- IBD: Genetics And Immunopathologic MechanismsNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2009
- Ibd:Tnf-Alpha And Crohn'S Disease Mucosal InflammationNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2008
- Immunopathology--Crohn'S Disease ImmunophenotypeNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2006
- Flagellin Reactivity As A Marker For A Subtype Of CrohnNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2006
- Core--Tissue Procurement /Data Analysis /Serum AnalysisNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2006
- Administration CoreNational Institute Of Diabetes And Digestive And Kidney Diseases2005
- Ibd--Mucosa-Specific Regulation Of Ifn-Gamma ProductionNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2005
- Ibd--Genetic And Immunopathologic MechanismsNational Institute Of Diabetes And Digestive And Kidney Diseases1995–2004
- TNF Alpha And Crohns Disease Mucosal InflammationNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2003
- IBD Disease Subgroup StratificationNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2002
- Core--Tissue Procurement FacilityNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2002
- Ibd--Immunogenetic Linkage And Subclinical MarkersNational Center For Research Resources1997–2001
- Ibd--Role Of Activated T-Cells In Gut InjuryNational Institute Of Diabetes And Digestive And Kidney Diseases1997–2000
- Trial Of IV Azathiprine Loading In Subjects With Steroid Refactory Crohn'S DISNational Center For Research Resources1997–1999
- Ulcerative Colitis Specific Panca--Role In Disease PathogenesisNational Institute Of Diabetes And Digestive And Kidney Diseases1996–1999
- Core--Tissue ProcurementNational Institute Of Diabetes And Digestive And Kidney Diseases1992–1999
- Ibd--Genetic &Immunopathologic MechanismsNational Institute Of Diabetes And Digestive And Kidney Diseases1994
- Activated T Cells And Gut InjuryNational Institute Of Diabetes And Digestive And Kidney Diseases1994
- Ibd--Genetic 7 Immunopathologic MechanismsNational Institute Of Diabetes And Digestive And Kidney Diseases1992–1994
- IBD: Role Of Antineutrophil Cytoplasmic AntibodiesNational Institute Of Diabetes And Digestive And Kidney Diseases1992–1993
- Role Of Activated T Cells In Gut InjuryNational Institute Of Diabetes And Digestive And Kidney Diseases1991–1993
- Ibd--Role Of Antineutrophil Cytoplasmic AntibodiesNational Institute Of Diabetes And Digestive And Kidney Diseases1992
- Role Of Activated T Cells In Gut InjuryNational Institute Of Diabetes And Digestive And Kidney Diseases1991
- IBD: Role Of Antineutrophil Cytoplasmic AntibodiesNational Institute Of Diabetes And Digestive And Kidney Diseases1991
- Mechanism Of The NK Lethal HIT In Programmed Tumor CellsNational Cancer Institute1985–1989
- Inflammatory Bowel Disease: NK Activity In Gut MucosaNational Institute Of Diabetes And Digestive And Kidney Diseases1986–1987
- Inflammatory Bowel Disease: NK Activity In Gut MucosaNat Inst Of Arthritis, Diabetes, Digestive &Kidney Diseases1985
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: